H

Hemostatics

10 employees

Hemostatics is developing a novel antifibrinolytic agent to reduce bleeding in life-threatening and disabling hemorrhagic conditions.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Heavy menstrual bleeding
Post-partum hemorrhage
Military Battlefield
haemorrhage
Pharmaceutical
Drug Discovery
Trauma
Bleeding
healthcare
ICH
Hereditary cerebral hemorrhage with amyloidosis
Health Care
Gastrointestinal bleeding
Medical
Osler-Weber-Rendu syndrome
Drug Development
pharma
Accidents

Date founded

2020

FAQ